ClinicalTrials.gg
DrugBiological

Prothrombin complex concentrate clinical trials

studies test it
22
open now
5
in phase 3
4
first study started
2005

How each study uses prothrombin complex concentrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the prothrombin complex concentrate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Apr 2013 · Kcentra · BLA 125421 (FDA, Purple Book)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Prothrombin Complex Concentrate
11
Prothrombin Complex Concentrate (PCC)
2
Beriplex P/N
2
Confidex®
2

Brand

Kcentra
1

Development codes

RVG 101094
1

In one entry with another drug

Given together, or one or the other

Prothrombin Complex Concentrate, Human
2
Beriplex® P/N (Kcentra)
2

Studies by the year they started

22 studies that test it; most in 2008 (2)

Studies that test prothrombin complex concentrate, by start year
YearStudies
20051
20082
20092
20101
20121
20141
20151
20162
20192
20202
20212
20231
20241
20251
20262

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
6
Phase 3
4
Phase 4
8
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 16

CSL Behring (4) · Konkuk University Medical Center (3) · Oregon Health and Science University (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Mayo Clinic (1) · Baxalta now part of Shire (1) · Queen Mary University of London (1) · Janssen Research & Development, LLC (1)

Often tested with

Tested in the same studies.

Homo sapiens whole (2) · Human plasma (2) · Four-factor Prothrombin Complex Concentrate (2) · Profilnine SD (1) · Fibrinogen (1) · Recombinant FVIIa (1)

Studies

Open first, then newest update. How each study uses prothrombin complex concentrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 22

See all 22 studies that test prothrombin complex concentrate →

As the comparator · 2 — what is tested is compared with prothrombin complex concentrate